Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
AI-focused Drug Discovery Firms Rise as FDA Phases Out Animal Testing
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Trending Industry Today: Tempus AI Leads Losses In AI Medical Concept Stocks
Ginkgo Bioworks, Partners Awarded $29 Million Contract to Stabilize Pharmaceutical Supply Chains
Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet
